Soluble neprilysin: A versatile biomarker for heart failure, cardiovascular diseases and diabetic complications—A systematic review

Soluble neprilysin: A versatile biomarker for heart failure, cardiovascular diseases and diabetic complications—A systematic review

The potential role of soluble neprilysin (sNEP) as a biomarker has been poorly documented. Hence, the present systematic review emphasizes to explore sNEP as an emerging biomarker for heart failure (HF), cardiovascular diseases, diabetic kidney diseases, and so on. A systematic review was performed...

Full description

Bibliographic Details
Main Authors:	Kumaresan Ramanathan, Giri Padmanabhan
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Indian Heart Journal
Subjects:	Soluble neprilysin Biomarker Heart failure Diabetic kidney disease A systematic review
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483220300225

Similar Items

Neprilysin Inhibitors and Bradykinin
by: Duncan J. Campbell, et al.
Published: (2018-09-01)

Breakthrough in Heart Failure therapy: LCZ696 combining ACE-Neprilysin inhibition
by: Sandeep Lahiry
Published: (2017-01-01)

Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure
by: Kawa Dizaye, et al.
Published: (2019-05-01)

Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence
by: Hong-Mi Choi, et al.
Published: (2020-05-01)

Inhibition of neprilysin with sacubitril without RAS blockage aggravates renal disease in Dahl SS rats
by: Iuliia Polina, et al.
Published: (2021-01-01)

The immuneregulator role of neprilysin (NEP) in invertebrates
by: E Ottaviani, et al.
Published: (2012-11-01)

The immuneregulator role of neprilysin (NEP) in invertebrates
by: E Ottaviani, et al.
Published: (2012-11-01)

Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01)

Neprilysin inhibition does not alter dynamic of proenkephalin‐A 119‐159 and pro‐substance P in heart failure
by: Henrike Arfsten, et al.
Published: (2021-06-01)

Long-Term Effects of Angiotensin Receptor–Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
by: Gregor Poglajen, et al.
Published: (2020-07-01)

Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study
by: Elena Revuelta‐López, et al.
Published: (2020-04-01)

Angiotensin receptor neprilysin inhibitor in inotrope dependent heart failure patients: A case series
by: Sepideh Taghavi, et al.
Published: (2020-12-01)

Circulating Neprilysin Level Predicts the Risk of Cardiovascular Events in Hemodialysis Patients
by: Hyeon Seok Hwang, et al.
Published: (2021-06-01)

Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
by: Jahanzeb Malik, et al.
Published: (2021-09-01)

Hypoxia affects neprilysin expression through caspase activation and an APP intracellular domain-dependent mechanism
by: Caroline eKerridge, et al.
Published: (2015-11-01)

The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
by: Emil Eik Nielsen, et al.
Published: (2019-10-01)

Blockade of the Neprilysin and Angiotensin Ameliorates Oxidative Stress in the Cardiovascular Target Tissues of Dexamethasone-induced Hypertensive Rats
by: Duygun Altıntaş Aykan, et al.
Published: (2020-01-01)

Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias
by: Henry Sutanto, et al.
Published: (2021-08-01)

Neuropeptides et Néprilysines : rôle dans la mémoire chez la Drosophile
by: Turrel, Oriane
Published: (2017)

Effects of canagliflozin on renal and urinary angiotensin converting enzyme 2 (ACE2) and neprilysin (NEP) in db/db diabetic mice
by: Thanekar, Unmesha Hemant
Published: (2019)

The Association between Neprilysin gene polymorphisms and Alzheimer’s disease in Tibetan population
by: Siwei Chen, et al.
Published: (2021-03-01)

Serum neprilysin levels are associated with myocardial stunning after ST-elevation myocardial infarction
by: Damien Legallois, et al.
Published: (2020-07-01)

Low‐fat hypocaloric diet reduces neprilysin in overweight and obese human subjects
by: Christine Henke, et al.
Published: (2021-04-01)

A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatient basis
by: Pankaj Jariwala, et al.
Published: (2021-03-01)

Effect of angiotensin receptor neprilysin inhibitor on ventricular remodeling after myocardial infarction in rats
by: Jian An
Published: (2020-11-01)

The effect of neprilysin and renin inhibition on the renal dysfunction following ischemia‐reperfusion injury in the rat
by: Fayez T. Hammad, et al.
Published: (2021-03-01)

Specific fluorogenic substrates for neprilysin (neutral endopeptidase, EC 3.4.24.11) which are highly resistant to serine- and metalloproteases
by: M.A.S. Medeiros, et al.
Published: (1997-10-01)

The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19
by: Alessandro Bellis, et al.
Published: (2020-11-01)

Effect of Neprilysin Inhibition for Ischemic Mitral Regurgitation after Myocardial Injury
by: Sahmin Lee, et al.
Published: (2021-08-01)

Soluble neprilysin and long-term clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cohort study
by: Ik Jun Choi, et al.
Published: (2020-08-01)

Real-world experience of angiotensin receptor/neprilysin inhibitor (ARNI) usage in Thailand: a single-center, retrospective analysis
by: Wipharak Rattanavipanon, et al.
Published: (2021-07-01)

Drosophila neprilysins control insulin signaling and food intake via cleavage of regulatory peptides
by: Benjamin Hallier, et al.
Published: (2016-12-01)

Royal jelly coordinately enhances hippocampal neuronal expression of somatostatin and neprilysin genes conferring neuronal protection against toxic soluble amyloid-β oligomers implicated in Alzheimer’s disease pathogenesis
by: Ichiro Kawahata, et al.
Published: (2018-12-01)

Pharmacodynamic and pharmacokinetic effects of S086, a novel angiotensin receptor neprilysin inhibitor
by: Jingchao Sun, et al.
Published: (2020-09-01)

Identification of neprilysin as a potential target of arteannuin using computational drug repositioning
by: Xuan-Yi Ye, et al.
Published: (2017-06-01)

Changes of serum Adropin protein and neprilysin levels in patients with type 2 diabetic retinopathy and analysis of influening factors
by: Xiao-Kang Zhang, et al.
Published: (2020-03-01)

Identification of novel physiological processes regulated by Neprilysin activity in Drosophila melanogaster
by: Hallier, Benjamin Christoph
Published: (2017)

The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat
by: Javad Habibi, et al.
Published: (2019-03-01)

Maternal Overweight Downregulates MME (Neprilysin) in Feto-Placental Endothelial Cells and in Cord Blood
by: Elisa Weiß, et al.
Published: (2020-01-01)

Expression of Neprilysin in Skeletal Muscle by Ultrasound-Mediated Gene Transfer (Sonoporation) Reduces Amyloid Burden for AD
by: Yuanli Li, et al.
Published: (2020-06-01)

Cannot write session to /tmp/vufind_sessions/sess_vt1929jgfmj95qjgivss6fuh3h